<DOC>
	<DOCNO>NCT00302523</DOCNO>
	<brief_summary>The purpose study : - To explore potential role tacrolimus treatment membranous nephropathy . - To investigate safety tolerability tacrolimus v methylprednisolone plus cyclophosphamide .</brief_summary>
	<brief_title>Tacrolimus Treatment Patients With Idiopathic Membranous Nephropathy</brief_title>
	<detailed_description>Idiopathic membranous nephropathy common cause nephrotic syndrome adult . Over past decade , number study report therapeutic efficacy treatment Cyclosporine-A ( CSA ) patient nephrotic syndrome include patient membranous nephropathy . This study evaluate safety effectiveness new calcineurin immunosuppressive drug , tacrolimus ( FK506 ) , reduce amount protein urine patient membranous nephropathy . Forty patient biopsy-proven membranous nephropathy recruit . Candidates must complete least six month treatment stable dose angiotensin convert enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARBs ) . They screen medical history , physical examination , blood test , examination infection , cancer , condition cause membranous nephropathy . The investigator plan conduct open-label study efficacy safety tacrolimus treatment membranous nephropathy . They treat oral tacrolimus 6 month , follow 6 month maintenance . Proteinuria , renal function monitor . Complete remission define 24-hour urinary protein excretion le 0.4 mg/day . This study explore potential role tacrolimus treatment membranous nephropathy , usually resistant conventional therapy .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , Membranous</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Biopsyproven idiopathic membranous nephropathy Nephrotic syndrome proteinuria ( &gt; 4 g/day ) serum albumin &lt; 30 g/dl Age 1860 year informed consent Patient abnormal liver function test Prior therapy sirolimus , CSA , MMF , azathioprin , cytoxan , chlorambucil , levamisole , methotrexate , nitrogen mustard last 90 day Active/serious infection Patient hepatitis B surface antigen hepatitis C antibody positive Patient diabetic Patient allergic intolerant macrolide antibiotic tacrolimus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Idiopathic Membranous Nephropathy</keyword>
	<keyword>Treatment</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Cyclophosphamide</keyword>
</DOC>